Skip to main content
Anke van den Berg
prof. dr.

I work as a clinical molecular biologist in the department of Pathology. In this function I supervise and implement advanced molecular diagnostic techniques. Within my research line, I focus on the molecular pathogenesis of B-cell Hodgkin and non-Hodgkin lymphoma. The specific fields of interest are genomic aberrations, genetic susceptibility, and the role of small and long noncoding RNAs. I have several international collaborations and am PI and co-PI in various projects.

Early-onset renal cell cancer and bilateral epididymal cysts as presenting symptoms of von Hippel-Landau disease
HY Kroes, RH Sijmons, Anke van den Berg, AH Van der Hout
An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell cancer and a t(2;3)(q35;q21) chromosome translocation
Through allele-segregation and loss-of-heterozygosity analyses, we demonstrated loss of the translocation-derivative chromosome 3 in five independent renal cell tumors of the clear-cell type, obtained from three members of a family in which a constitutional t(2;3)(q35;q21) was encountered. In addition, analysis of the von Hippel-Lindau gene, VHL, revealed distinct insertion, deletion, and substitution mutations in four of the five tumors tested. On the basis of these results, we conclude that, in this familial case, an alternative route for renal cell carcinoma development is implied. In contrast to the first...
D Bodmer, MJ Eleveld, MJL Ligtenberg, MAJ Weterman, BAP Janssen, DFCM Smeets, PEJ de Wit, Anke van den Berg, E van den Berg, MI Koolen, AG van Kessel
A cosmid and cDNA fine physical map of a human chromosome 13q14 region frequently lost in B-cell chronic lymphocytic leukemia and identification of a new putative tumor suppressor gene, Leu5
Published in: FEBS Letters
B-cell chronic lymphocytic leukemia (B-CLL) is a human hematological neoplastic disease often associated with the toss of a chromosome 13 region between RB1 gene and locus D13S25, A new tumor suppressor gene (TSG) may be located in the region. A cosmid contig has been constructed between the Loci D13S1168 (W19598) and D13S25 (H2-42), which corresponds to the minimal region shared by B-CLL associated deletions. The contig includes more than 200 LANL and ICRF cosmid clones covering 620 kb, Three cDNAs likely corresponding to three different genes hare been...
B Kapanadze, V Kashuba, A Baranova, O Rasool, W van Everdink, A Syomov, M Corcoran, A Poltaraus, V Brodyansky, N Syomova, A Kazakov, R Ibbotson, Anke van den Berg, R Gizatullin, L Fedorova, G Sulimova, A Zelenin, L Deaven, H Lehrach, D GranderC Buys, D Oscier, ER Zabarovsky, S Einhorn, N Yankovsky
Immune escape mechanisms in Hodgkin’s disease
Background: The nodular sclerosis and mixed cellularity subtypes of Hodgkin’s disease are histologically characterised by a small population of neoplastic cells, the so-called Reed-Sternberg cells and their mononuclear variants (RS cells) and an extensive admixture of other cell types including lymphocytes, plasma cells, eosinophils, and histiocytes. The nature of this infiltrate is largely known, but the mechanisms and functional effects are not. The small lymphocytes immediately surrounding the RS cells are mostly CD4+ T cells that express early activation markers. The absence of prominent specific cytotoxic I cell...
S Poppema, M Potters, L Visser, A. van den Berg
Analysis of multiple renal cell adenomas and carcinomas suggests allelic loss at 3p21 to be a prerequisite for malignant development
Multiple renal cell rumours from three unrelated patients have been analysed for loss of heterozygosity of 3p, mutation of VHL, and chromosome 7 and 17 imbalances, Loss of 3p alleles is characteristic for clear cell type tumours and the combination of +7, +17 for chromophilic cell type rumours. Thus, we could classify adenomas and carcinomas of the three patients according to the genomic patterns of the tumours. Adenomas appeared to be mostly of the chromophilic cell type. In some adenomas, however, allelic losses of chromosome 3 were detected,...
Anke van den Berg, T Dijkhuizen, TG Draaijers, MMF Hulsbeek, ER Maher, E vandenBerg, S Storkel, CHCM Buys